Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nitric Oxide
100%
Erectile Dysfunction
100%
Medical Therapy
100%
Cyclic GMP
50%
Phosphodiesterase Type 5 Inhibitors
37%
Erectile Function
25%
Non-cholinergic
25%
Penile Erection
25%
Neurotransmitters
12%
Hypertension
12%
Cardiovascular Disease
12%
Multifactorial Disorder
12%
Aging
12%
Tolerability
12%
Corpus Cavernosum
12%
Penis
12%
Pathogenic Mechanism
12%
Success Rate
12%
Additional Therapy
12%
Bioactivity
12%
Calcium Channel
12%
Hypercholesterolemia
12%
Endothelial Cells
12%
Nerve Cells
12%
Nitric Oxide Donors
12%
Chemical Mediators
12%
Second Messenger
12%
Contractile Proteins
12%
Soluble Guanylyl Cyclase
12%
Erectile Dysfunction Drugs
12%
Cardiovascular Depression
12%
Corpus Cavernosum Smooth muscle Cell
12%
Diabetes Mellitus
12%
Neurovascular
12%
Soluble Guanylate Cyclase Activator
12%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Erectile Dysfunction
100%
Cyclic GMP
50%
Phosphodiesterase V Inhibitor
37%
Guanylate Cyclase
25%
Neurotransmitter
12%
Diabetes Mellitus
12%
Tolerability
12%
Hypercholesterolemia
12%
Nitric Oxide Donor
12%
Calcium Channel
12%
Contractile Protein
12%
Guanylate Cyclase Activator
12%
Cardiovascular Disease
12%
Diseases
12%
Hypertension
12%